According to the results declared on 09 Nov, 2023, the company’s revenue increased by 15.92% compared to the same quarter last year.
The profit also witnessed a significant growth of 83.88% year-over-year.
In comparison to the previous quarter, the revenue grew by 5.71% and the profit increased by 78.32%.
The company’s Selling, General & Administrative expenses rose by 0.34% quarter-over-quarter and increased by 12.92% year-over-year.
On the other hand, the operating income showed a positive trend with a growth of 25.09% quarter-over-quarter and 22.29% year-over-year.
The earnings per share (EPS) for the second quarter of fiscal year 2024 stood at ₹0.97, representing a significant increase of 83.02% year-over-year.
Healthcare Global Enterprises has also delivered impressive returns for its investors.
In the last 1 week, the company’s stock has provided a return of 0.21%.
Over the last 6 months, the stock has performed exceptionally well, delivering a return of 35.11%.
Year-to-date, the stock has generated a return of 29.8%.
The company currently has a market capitalization of ₹5195.61 Cr and its 52-week high and low are ₹380.35 and ₹253.15 respectively.
Analysts have also shown positive sentiment towards Healthcare Global Enterprises.
Out of 6 analysts covering the company, 4 analysts have given a Buy rating and 2 analysts have given a Strong Buy rating.
As of 12 Nov, 2023, the consensus recommendation for the stock was to Strong Buy.
| Period | Q2 FY24 | Q1 FY24 | Q-o-Q Growth | Q2 FY23 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 485.96 | 459.71 | +5.71% | 419.21 | +15.92% |
| Selling/ General/ Admin Expenses Total | 77.16 | 76.9 | +0.34% | 68.33 | +12.92% |
| Depreciation/ Amortization | 43.21 | 41.01 | +5.36% | 40.83 | +5.83% |
| Total Operating Expense | 445.52 | 427.38 | +4.24% | 386.14 | +15.38% |
| Operating Income | 40.44 | 32.33 | +25.09% | 33.07 | +22.29% |
| Net Income Before Taxes | 17.92 | 10.52 | +70.34% | 10.02 | +78.84% |
| Net Income | 13.57 | 7.61 | +78.32% | 7.38 | +83.88% |
| Diluted Normalized EPS | 0.97 | 0.54 | +79.63% | 0.53 | +83.02% |
FAQs
Question : What is the Q2 FY24 profit/Loss as per company?
Ans : ₹13.57Cr
Question : What is Q2 FY24 revenue?
Ans : ₹485.96Cr
Stay updated on quarterly results with our results calendar
Milestone Alert!Livemint tops charts as the fastest growing news website in the world 🌏 Click here to know more.
Download The Mint News App to get Daily Market Updates & Live Business News.
More
Less
Updated: 12 Nov 2023, 02:15 AM IST
link
More Stories
Global Home Healthcare Software Business Report 2023:
Global Healthcare Third-party Logistics Market Size and Growth Will Reach USD 415.24 Billion By 2032, at 7.4% CAGR: Polaris Market Research
The 10 Biggest Trends Revolutionizing Healthcare In 2024